Please wait while the formulary information is being retrieved.
SORBUTUSS (GUAIFENESIN/DEXTROMETHORPHAN HBR/POTASSIUM CITRATE)
- Cough
10 mg-100 mg-85 mg/5 mL oral liquid
- Dosage information is not available
- Azilect
- Eldepryl
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- None
Severe
Moderate
- Adderall
- Adderall Xr
- Amphetamine Salt Combo
- benzphetamine
- Bronchial Asthma Relief
- Bronkaid Dual Action
- Desoxyn
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- dextromethorphan-quinidine
- Didrex
- ephedrine sulfate
- ephedrine sulfate-guaifenesin
- ephedrine-guaifenesin
- levmetamfetamine
- lisdexamfetamine
- methamphetamine
- midodrine
- Nuedexta
- Primatene Asthma
- Procentra
- quinidine gluconate
- quinidine sulfate
- Regimex
- Vapor Inhaler
- Vyvanse
- Zenzedi
- Familial hyperkalemic periodic paralysis
- Hyperkalemia
Contraindicated
- Anuria
- Dehydration
- Oliguria
- Primary adrenocortical insufficiency
- Renal disease with moderate to severe impairment
- Severe chronic heart failure
- Systemic mastocytosis
Severe
Moderate
- No disease contraindications
SORBUTUSS (GUAIFENESIN/DEXTROMETHORPHAN HBR/POTASSIUM CITRATE)
- Cough
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Vomiting
Less Severe
- Abdominal pain with cramps
- Dizziness
- Drowsy
- Gastrointestinal irritation
- Nausea
- Vomiting
Contraindicated
Dextromethorphan (OTC)
Do not use in pediatrics <6 years of age unless clinician consultation.
- 1 Day – 6 Years
- 1 Do not use in pediatrics <6 years of age unless clinician consultation.
Severe Precaution
Guaifenesin (Liquid)
No established efficacy for cough and cold products age < 2 years. Do not use unless directed by clinician consultation.
- 1 Day – 2 Years
- No established efficacy for cough and cold products age < 2 years. Do not use unless directed by clinician consultation.
Management or Monitoring Precaution
Potassium
Assess renal function prior to giving potassium.
- 1 Day – 2 Days
- Assess renal function prior to giving potassium.
Dextromethorphan
- Severity Level:
C
- Additional Notes:
Guaifenesin
- Severity Level:
C
- Additional Notes:
Potassium Citrates
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Dextromethorphan
Insufficient data available; molecular wt low enough for possible excretion
Insufficient data available
No adv effects expected if maternal serum potass level in physiologic range
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; molecular wt low enough for possible excretion |
Guaifenesin
Insufficient data available; molecular wt low enough for possible excretion
Insufficient data available
No adv effects expected if maternal serum potass level in physiologic range
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
Potassium Citrate
Insufficient data available; molecular wt low enough for possible excretion
Insufficient data available
No adv effects expected if maternal serum potass level in physiologic range
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | No adv effects expected if maternal serum potass level in physiologic range |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Potassium Salts (oral)
Renal-Decreased doses may be necessary in advanced renal dysfunction. Monitor serum potassium levels more closely. Gastrointestinal-Increased risk for gastritis.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Cough | |
| R05 | Cough |
| 0-9 | A-Z |
|---|---|
| R05 | Cough |
Formulary Reference Tool